This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Fenchone is an ingredient used in medication to treat kidney, bladder, and urinary tract stones.

Generic Name
Fenchone
DrugBank Accession Number
DB15918
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 152.237
Monoisotopic: 152.120115135
Chemical Formula
C10H16O
Synonyms
  • (+/-)-Fenchone
  • DL-Fenchone
  • Fenchon
External IDs
  • 214-804-6
  • NSC-122687
  • NSC-8896

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
URINEX (Enteric-Coated) Soft Gelatin CapsulesFenchone (4 mg) + Anethole (4 mg) + Borneol (10 mg) + Camphene (15 mg) + Eucalyptol (3 mg) + alpha-Pinene (24.8 mg) + beta-Pinene (6.2 mg)Capsule, gelatin coatedOralPharco Health Sdn. Bhd2020-09-08Not applicableMalaysia flag
โรวาทีเน็กFenchone (4 mg) + Anethole (4 mg) + Borneol (10 mg) + Camphene (15 mg) + Eucalyptol (3 mg) + alpha-Pinene (24.8 mg) + beta-Pinene (6.2 mg)Capsuleบริษัท ดีซีเอช ออริกา (ประเทศไทย) จำกัด1987-05-22Not applicableThailand flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
4Q6W8568TG
CAS number
1195-79-5
InChI Key
LHXDLQBQYFFVNW-OIBJUYFYSA-N
InChI
InChI=1S/C10H16O/c1-9(2)7-4-5-10(3,6-7)8(9)11/h7H,4-6H2,1-3H3/t7-,10+/m0/s1
IUPAC Name
(1R,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-one
SMILES
CC1(C)[C@H]2CC[C@](C)(C2)C1=O

References

General References
  1. FDA Thailand: Rowatinex (Anethole, Borneol, Camphene, Eucalyptol, Fenchone, Alpha-Pinene, Beta-Pinene) Capsule [Link]
ChemSpider
74207
ChEBI
36612
ZINC
ZINC000000967570
Wikipedia
Fenchone

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Capsule, gelatin coatedOral
Capsule
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.883 mg/mLALOGPS
logP2.54ALOGPS
logP3.06ChemAxon
logS-2.2ALOGPS
pKa (Strongest Basic)-7.6ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area17.07 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity44.54 m3·mol-1ChemAxon
Polarizability17.86 Å3ChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created at November 23, 2020 14:47 / Updated at May 07, 2021 21:08